Tag Archives: interferon beta 1-a

Early therapy delays progression to clinically definite multiple sclerosis

mdCurrent Conference Report: 64th American Academy of Neurology Annual Meeting Data from 2 major phase 3 trials have demonstrated that progression to clinically definite multiple sclerosis (MS) can be prevented or delayed with early rather than delayed therapy. Two regimens of subcutaneous interferon beta-1a (IFNb) were evaluated in patients who… 

Read more »
Posted in mdCurrent Conference Reports, Neurology, Pharmacology | Also tagged , , , , , , , , , | Volume: | Leave a comment